(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 2.87% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.71%.
Airsculpt Technologies's revenue in 2026 is $151,836,000.On average, 4 Wall Street analysts forecast AIRS's revenue for 2026 to be $11,034,755,422, with the lowest AIRS revenue forecast at $10,563,510,273, and the highest AIRS revenue forecast at $11,400,182,050. On average, 4 Wall Street analysts forecast AIRS's revenue for 2027 to be $11,311,294,492, with the lowest AIRS revenue forecast at $10,826,645,663, and the highest AIRS revenue forecast at $11,688,713,885.
In 2028, AIRS is forecast to generate $11,656,968,328 in revenue, with the lowest revenue forecast at $11,096,130,164 and the highest revenue forecast at $12,111,282,514.